RE:Novadaq Technologies, Inc. Analyst Notes Info on NDQ-this is being touted by Stansberry Research, they have a 'PRO" hired that is saying this stock can be worth a 500% gainer or far more,because of their Pinpoint Surgery.The person who is making this claim is Paul Mampilly,who,at 45, has made a fortune on specs,He recommended NDQ at $12.40 a short time ago,and it has gone up over 30% since.Stansberry wants $2500 for joining and the 2nd year is free.You can find out more about Stansberry & Mampilly on Google...I do not own shares in NDQ,but am thinking about it.Ihope this is helpful to all the shareholders of NDQ.Cheers DD